Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

1.67%

30.5¢ paradigm biopharmaceuticals limited..

Current SP appreciation, page-148

First 148 Last

Share
Profile

Follow
seventhseal

1,365 Posts.

488

08/10/19

09:18

Post #: 40767082
Share

Originally posted by Mozzarc: ↑

Ok perhaps I can shed some light on this one...

First I have to unfortunately give credit where it is due, Sam managed to beat me by 12 hours by giving us a clue on the status of the 10 American patient program...I don't know why she is withholding details:

I was curious as to the timing of these 10 Star American Footballers and Im not counting on PAR to give us an update (not their fault, they are busy and have a small team, they cant do everything and cater to every investor's wishes and whims). So I called them.No no not PAR..I called Dr Michels clinique!

I simply asked for the timing on where these star studded players are at (Yes I might have put on slightly American accent to smooth over my questioning)and guess what they said: The said they haven't started yet but (I want to say it sounds like it is 'imminent') they are "very close to starting". I'm guessing that means within a week. (My view)

Now based on this we get to work *rubs hands together*..timings and forecasting...love it.
Why is timing so relevant? Because in the interim and in the absence of any other news, if we wait till the end of the program and the lab results we can understand if the SP of PAR drifts down for example...we wont be worried because we know whats happening in the background. Some shareholders will get bored and start wondering whats happening and may start selling parts of their holdings...we ourselves know whats happening and wont be in that position. In fact we could take advantage of this if the SP drops too low.

Ok so according to the 6 week program if we start next week that will take us up to the 25th of November. After this the predesignated lab gets receipt of the results, lets give them a week to compile it together...now the analysis has taken quite a while in the past..I'm talking 2 months minimum.Maybe PAR will try and hurry them (the lab) up but probably they cant and the lab will take their own time. I don't know if they will use the same lab as we are using for the Clinical 2 Trail or will it be a local (US) lab? At any rate we can easily add up to 2 full months on to the end which now puts us at end of Jan 2020. .Exciting times, hold on to your hats..and your shares. My views.

Expand

Appreciate your many posts here mate but respectfully disagree with what seems to be an underlying assumption of this post: an unknown delay to a promo trial of 10 NFL players being a key firver of the SP in the short term. Sure its potentially 1 less news catalyst in the short term. But thats all it is. I think we and they are pretty clear on what the results will be. That may impact some impatient retail holders, biut thats all. Pro money wont give 2 hoots IMO. And pro money wil be deciding where the SP goes next IMO.

Last edited by seventhseal: 08/10/19

PAR Price at posting: $3.05 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AI stocks: What to expect in 2024-25

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

There are more pages in this discussion • 111 more messages in this thread...

First 148 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 30.5¢		Change 0.005(1.67%)		Mkt cap ! $106.6M

Open	High	Low	Value	Volume
30.5¢	31.5¢	29.5¢	$152.7K	501.9K

Buyers (Bids)

No.	Vol.	Price($)
2	16864	30.5¢

Sellers (Offers)

Price($)	Vol.	No.
31.5¢	20426	2

View Market Depth

No.	Vol.	Price($)
2	16864	0.305
1	62640	0.300
4	99959	0.295
5	18241	0.290
3	51043	0.285

Price($)	Vol.	No.
0.315	20426	2
0.320	55000	2
0.325	50366	4
0.330	56660	4
0.335	13500	2

Last trade - 16.10pm 17/07/2024 (20 minute delay)

PAR (ASX) Chart

Current SP appreciation, page-148

AI stocks: What to expect in 2024-25

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Current SP appreciation, page-148

Top Stories

AI stocks: What to expect in 2024-25

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News